Seven Eight Capital »

Immunovant shares owned by Seven Eight Capital

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Seven Eight Capital from 13F filings

Historical chart of Seven Eight Capital investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Seven Eight Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Seven Eight Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.7M 45k 38.39
2023-06-30 $870k 46k 18.97

More positions owned by Seven Eight Capital

Edwards Lifesciences (EW)
Merck & Co (MRK)
Las Vegas Sands (LVS)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Vertex Pharmaceuticals Incorporated (VRTX)
Vertiv Holdings Com Cl A (VRT)
Intuitive Surgical Com New (ISRG)
ResMed (RMD)
Docusign (DOCU)
Fiserv (FI)
Xylem (XYL)
Meta Platforms Cl A (META)
Jabil Circuit (JBL)
Nextera Energy (NEE)

View all positions for Seven Eight Capital

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Dimensional Fund Advisors
Ikarian Capital

View all funds holding Immunovant